Últimos Artículos de Terapeuthic Advances in Endocrinolgy and Metabolism
- Gut microbiota in MAFLD: therapeutic and diagnostic implications
- Age-related markers and predictors of diabetic kidney disease progression in type 2 diabetes patients: a retrospective cohort study
- The impact of socioeconomic factors, social determinants, and ethnicity on the utilization of glucose sensor technology among persons with diabetes mellitus: a narrative review
- Role of epicardial adipose tissue in diabetic cardiomyopathy through the lens of cardiovascular magnetic resonance imaging – a narrative review
- Epidemiology of gout – Global burden of disease research from 1990 to 2019 and future trend predictions
- Insulin therapy among diabetic patients in rural communities of Sub-Saharan Africa: a perspective review
- Liver Biopsy Handling of Metabolic-Associated Fatty Liver Disease (MAFLD): the Children’s Hospital of Eastern Ontario grossing protocol
- Anti-inflammatory role of glucagon-like peptide 1 receptor agonists and its clinical implications
- Therapeutic potential of adiponectin in prediabetes: strategies, challenges, and future directions
- Glycogen storage disease type III: a mixed-methods study to assess the burden of disease
- Semaglutide in the spotlight: weighing benefits against rising concerns
- Hippo/YAP signaling pathway: a new therapeutic target for diabetes mellitus and vascular complications
- Dual-basal-insulin regimen for the management of dawn phenomenon in children with type 1 diabetes: a retrospective cohort study
- Assessing the prediction of type 2 diabetes risk using polygenic and clinical risk scores in South Asian study populations
- Zoledronic acid sequential to teriparatide may promote greater inhibition of bone resorption than zoledronic acid alone
- Hypovitaminosis D masking hypercalcemia in primary hyperparathyroidism: case report
- Soluble tumor necrosis factor receptor type 1 predicts cardiorenal outcomes and better associated with distinct cardiovascular or renal outcomes than precedential renal or cardiovascular events in type 2 diabetes mellitus
- Pheochromocytoma: a changing perspective and current concepts
- Design and rationale for the SIB trial: a randomized parallel comparison of semaglutide versus placebo on intestinal barrier function in type 2 diabetes mellitus
- Efficacy of zoledronate, denosumab or teriparatide in postmenopausal women with type 2 diabetes mellitus at high risk of fragility fractures: protocol of an open, blinded endpoint randomized controlled pilot trial